- Home
- PDFS vs IMTX Comparison
PDFS vs IMTX Comparison
Compare PDFS & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDFS
- IMTX
- Stock Information
- Founded
- PDFS 1992
- IMTX N/A
- Country
- PDFS United States
- IMTX Germany
- Employees
- PDFS N/A
- IMTX N/A
- Industry
- PDFS EDP Services
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PDFS Technology
- IMTX Health Care
- Exchange
- PDFS Nasdaq
- IMTX Nasdaq
- Market Cap
- PDFS 1.1B
- IMTX 954.2M
- IPO Year
- PDFS N/A
- IMTX N/A
- Fundamental
- Price
- PDFS $27.88
- IMTX $5.35
- Analyst Decision
- PDFS Strong Buy
- IMTX Strong Buy
- Analyst Count
- PDFS 3
- IMTX 4
- Target Price
- PDFS $42.33
- IMTX $16.67
- AVG Volume (30 Days)
- PDFS 180.5K
- IMTX 988.8K
- Earning Date
- PDFS 02-13-2025
- IMTX 11-18-2024
- Dividend Yield
- PDFS N/A
- IMTX N/A
- EPS Growth
- PDFS 56.69
- IMTX N/A
- EPS
- PDFS 0.11
- IMTX N/A
- Revenue
- PDFS $170,505,000.00
- IMTX $128,824,447.00
- Revenue This Year
- PDFS $10.26
- IMTX $116.22
- Revenue Next Year
- PDFS $20.06
- IMTX N/A
- P/E Ratio
- PDFS $253.36
- IMTX N/A
- Revenue Growth
- PDFS 3.19
- IMTX 52.53
- 52 Week Low
- PDFS $26.60
- IMTX $5.28
- 52 Week High
- PDFS $39.70
- IMTX $13.77
- Technical
- Relative Strength Index (RSI)
- PDFS 45.20
- IMTX 21.22
- Support Level
- PDFS $26.60
- IMTX $7.00
- Resistance Level
- PDFS $28.30
- IMTX $7.42
- Average True Range (ATR)
- PDFS 0.89
- IMTX 0.41
- MACD
- PDFS 0.03
- IMTX -0.14
- Stochastic Oscillator
- PDFS 44.14
- IMTX 2.90
About PDFS PDF Solutions Inc.
PDF Solutions Inc offers products and services designed to empower engineers and data scientists across the semiconductor ecosystem to improve the yield, quality, and profitability of their products. The solutions combine proprietary software, physical intellectual property (or IP) for integrated circuit (or IC) designs, electrical measurement hardware tools, various methodologies, and professional services. The company's products and services are sold to integrated device manufacturers (or IDMs), fabless semiconductor companies, foundries, outsourced semiconductor assembly and test (or OSATs), and system houses.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.